AC Immune (ACIU) Share-based Compensation (2015 - 2025)

AC Immune (ACIU) has 11 years of Share-based Compensation data on file, last reported at $1.1 million in Q4 2025.

• On a quarterly basis, Share-based Compensation rose 2.46% year-over-year to $1.1 million in Q4 2025; TTM through Dec 2025 was $5.2 million, a 15.82% decrease from a year earlier, with the FY2025 full-year figure at $5.3 million, down 15.09% from the prior year.
• Share-based Compensation for Q4 2025 stood at $1.1 million, up from $1.0 million in the prior quarter.
• Over the last five years, Share-based Compensation for ACIU reached as high as $2.2 million in Q1 2024 and fell as low as $574678.4 in Q3 2022.
• Historically, Share-based Compensation has averaged $1.2 million across 5 years, with a median of $1.1 million in 2024.
• Across the five-year window, Share-based Compensation tumbled 61.96% in 2022 and soared 70.8% in 2023, its largest moves.
• Year by year, Share-based Compensation stood at $1.1 million in 2021, then slipped by 18.57% to $922801.5 in 2022, then decreased by 2.63% to $898501.5 in 2023, then advanced by 22.85% to $1.1 million in 2024, then gained by 2.46% to $1.1 million in 2025.
• Per Business Quant data, the three most recent Share-based Compensation figures were $1.1 million in Q4 2025, $1.0 million in Q3 2025, and $1.4 million in Q2 2025.